RxDoctor Payments DataLook up a doctor →

Meghan Cogswell, PA

Medical · Colorado Springs, CONPI 1427287002

Payments from drug & device makers

$17,644in general payments, 2019–2025

Across 623 payments — averaging $28.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$2K
  • AbbVie$2K
  • Abbott$2K
  • Biogen$835
  • Novartis$711
  • Pfizer$592
  • plus $9K from 54 others

What the payments were for

  • Speaking & faculty fees$620%
  • Travel & lodging$9876%
  • Food & beverage$16,48593%
  • Education$1111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.54$2,368
AbbVie(2 entities)107$1,904
Abbott19$1,715
Biogen32$835
Novartis35$711
Pfizer33$592
Jazz Pharmaceuticals Inc.16$554
Neurocrine Biosciences, Inc.29$542
AstraZeneca(2 entities)20$533
Sanofi24$532
UCB, Inc.12$473
Neurelis, Inc.8$391
Merz Pharmaceuticals, LLC16$377
Eisai Inc.14$368
Lilly USA, LLC16$361
Biohaven Pharmaceuticals, Inc.15$347
Livanova USA, Inc.6$330
Acorda Therapeutics, Inc8$272
Argenx US, Inc.7$264
TG Therapeutics, Inc.11$255
Bristol Myers Squibb18$250
SK Life Science, Inc.9$249
Genentech USA, Inc.5$235
Acadia Pharmaceuticals Inc8$229
E.r. Squibb & Sons, L.L.C.2$218
Tanabe Pharma America, Inc.11$214
Amgen(2 entities)8$203
Boston Scientific2$163
Biohaven Pharmaceutical Holding Company Ltd.8$161
Averitas Pharma Inc.3$160
Vanda Pharmaceuticals Inc.2$142
Lundbeck LLC4$140
Harmony Biosciences LLC4$138
Octapharma USA, Inc.5$115
Takeda Pharmaceuticals U.S.A., Inc.1$97
Janssen Scientific Affairs, LLC1$91
ANI Pharmaceuticals, Inc.4$89
Teva Pharmaceuticals USA, Inc.5$86
Amneal Pharmaceuticals LLC3$84
Ipsen Biopharmaceuticals, Inc4$83
CSL Behring2$70
Avion Pharmaceuticals3$69
Grifols USA, LLC2$65
Greenwich Biosciences, Inc.3$64
Collegium Pharmaceutical, Inc.2$46
Ultragenyx Pharmaceutical Inc.2$42
Philips North America LLC1$42
Alnylam Pharmaceuticals Inc.2$40
Sunovion Pharmaceuticals Inc.2$40
Kyowa Kirin, Inc.2$36
Amylyx Pharmaceuticals, Inc.1$25
Impel Pharmaceuticals Inc.1$24
Mallinckrodt Hospital Products Inc.1$23
GE HealthCare1$23
Banner Life Sciences, LLC1$22
MDD US Operations, LLC1$22
Johnson & Johnson1$21
Genentech, Inc.1$21
Supernus Pharmaceuticals, Inc.1$21
Avanir Pharmaceuticals, Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,644 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$34,685
Medicare patients
236
Services billed
320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab23$191,970
Emgality PenGalcanezumab-Gnlm34$33,094
Aimovig AutoinjectorErenumab-Aooe22$22,612
Nurtec OdtRimegepant Sulfate12$22,165
UbrelvyUbrogepant19$22,099
RytaryCarbidopa/Levodopa13$17,840
Ajovy AutoinjectorFremanezumab-Vfrm15$17,491
Rufinamide12$7,082
Levetiracetam53$2,992
Gabapentin79$2,838
Carbamazepine ErCarbamazepine13$2,381
Carbidopa-LevodopaCarbidopa/Levodopa69$1,578
Carbidopa-Levodopa ErCarbidopa/Levodopa25$1,288
Ropinirole Hcl47$1,270
Memantine Hcl36$1,185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$592$22,16512 claims
AbbVieUbrelvy$1,904$22,09919 claims
Amneal Pharmaceuticals LLCRytary$84$17,84013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.

Other medical in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →